Health • May 20, 2026
New drug approach offers hope for patients with recurrent aggressive cancers
Originally published on Fox News Health
Merck announces that sac-TMT, a new cancer drug, demonstrated strong results in phase 3 trials for advanced or recurrent endometrial cancer patients.
Merck announces that sac-TMT, a new cancer drug, demonstrated strong results in phase 3 trials for advanced or recurrent endometrial cancer patients.
Originally published on Fox News Health.
More good news
- A little kid snuck into his older brother’s game and somehow ended up getting his very first red card.
- Fairies 🧚
- (OC) I won the parents lottery! They are soon celebrating their 58th wedding anniversary. They always put me and my late brother Brett first. They've given me everything, even when I didn't deserve it. Tragedy only made them closer, and the good times far outweigh the bad. I love them so much!
- The hat my wife and kids handmade me for Father's Day